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It is believed now that these drugs are useful in the treatment of ischemic disease.
In an effort to define which drugs could offer the best therapeutic alternative, a comparative pharmacological study was made. Nine drugs (D-600 diltiazem, flunarizine, nicardipine, nifedipine, nimodipine, nitrendipine, verapamil, tiapamil) were tested in experimental screening models of brain hypoxia, ischemia, cellular intoxication and against bicuculline induced seizures.
Three types of activity were found. Verapamil, D-600, tiapamil and diltiazem were almost inactive, possibly due to their poor brain penetration. The dihydropyridines had a broad spectrum of activity, but considerable differences between these compounds exist. They all were active against hypoxia and less active against ischemia.
Out of this subgroup, only nicardipine protected against metabolic intoxication and nifedipine and nicardipine could block seizure com ponents at very high doses.
Flunarizine was the only compound with a dose related effect in all the tests. These results suggested that this combination of screening tests could be used to find compounds with an interesting activity in the field of cerebral protection.
Experimental
and clinical data on intra operative use of barbiturates suggest that these compounds have protective effects in cerebral focal ischemia (1) (2) (3) . However, the originally reported beneficial effects against global ischemia (4) have not always been confirmed (e.g. 5). Furthermore, the cardio respiratory depressant effects of these drugs limit possible benefits.
Recent hypotheses suggest that intra cellular accumulation of calcium is a common denominator of ischemic cellular damage (6, 7) . Therefore, prevention of excessive calcium entry may protect the brain (8) . Histological evidence demonstrates that hypoxia is associated with intracellular ac cumulation of calcium which can be pre vented by certain calcium entry blockers (9) .
In in vitro pharmacological tests, ,"Ca2+ entry blockers" have been subdivided into 3 different types. Dihydropyridines (nimodipine, nifedipine) block voltage-dependent Ca2+ channels in striated muscles, at lower doses than those altering smooth muscle tone. Compounds like flunarizine are specific anti vasoconstrictors, and they show little or no negative ionotrophic effects (10) . Thirdly, compounds like verapamil and D-600 prevent Ca2+-entry into both smooth and striated muscle. Although, nitrendipine binding sites are present in the brain, there is thus far no correlation between inhibition of 3H nitrendipine binding and any pharmacological test (11-13).
Further, little is known about the penetrability of the blood brain barrier to ,"Ca2+ -entry blockers" , definitive values only being available for flunarizine (14) .
The development of new methods of preventing cerebral damage after ischemia or hypoxia is a major research interest of this laboratory.
At present, the "Ca2+-entry blockers" represent the most viable phar macological possibility for treating ischemic disease. We are therefore interested in defining what type of "Ca2+-entry blocker" represents the best therapeutic alternative, which necessitates comparative phar macological studies. These types of studies are impossible in large complicated clinically-relevant" models such as cardiac arrest in dogs (15) . Therefore, as a first step in this study, we present here comparative studies of "Ca2+-entry blockers" in a series of experimental screening models of brain hypoxia, ischemia and cellular metabolic intoxication.
Further seizures and hypoxic damage are both associated with an excessive influx of calcium. Therefore, the "Ca2+-entry blockers"
were also tested against con vulsive seizures induced by bicuculline.
Materials and Methods

Tests
Brain hypoxia: nitrogen exposure: The experiments were performed on male Wistar rats (200±10 g), deprived of food overnight. They were placed for 1 min in a container with a pure nitrogen atmosphere. Thereafter, they were removed from the container and placed in an observation cage. Survival was scored after removal from the closed container (16) .
Complete ischemia: The experiments were performed on male Swiss mice (25 g), deprived of food overnight. They were decapitated caudal to the intersection of the medulla and the spinal cord. The time between decapitation and the last gasp (duration of gasping) was recorded.
Metabolic poisoning: histotoxic dysoxia test: The experiments were performed on male Wistar rats (200 g), deprived of food overnight.
They were given a rapid i.v. injection of 5 mg/kg of potassium cyanide (KCN) and scored for mortality 2 hr after the injection (16) .
Bicuculline seizure test: The experiments were performed on male Wistar rats (200 g) , deprived of food overnight. They were given an i.v. injection of 1.25 mg/kg of bicuculline. The following phenomena were observed: the presence or absence of clonic seizures, tonic backward extension of the forepaw , tonic extension of the hindpaw and mortality. administration. Complete ischemia Figure 1 shows the results obtained in controls and drug-treated mice, respectively, after i.p. (-1 hr) and p.o. (-4 hr) adminis tration.
After i.p. administration, flunarizine and nitrendipine dose-relatedly increased the duration of gasping. D-600 and tiapamil were inactive. Verapamil, diltiazem and nicardipine increased the duration of gasping only at the highest dose tested (40 mg/kg). Nimodipine was active at 2.5 and 40 mg/kg. Nifedipine increased the duration of gasping at 10 mg/ kg and decreased it at 40 mg/kg. Bicuculline seizure test Controls: A total of 84 control rats were tested. At the dose of bicuculline given, all animals showed clonic and tonic convulsions. Mortality was observed in 78 animals (7.1% survival).
Drug effects: Table 3 
Discussion
As mentioned in the introduction, it has been demonstrated that in experimental cerebral ischemia, extracellular Ca2+ decreases very soon after the insult and that total brain Ca2+ rises during the reperfusion period. This led to the proposal that sustained Ca2+-entry is the basis of neuronal toxicity in ischemia/ hypoxia (6) . Histological evidence obtained using the oxalate-pyroantimonate technique has unequivocally demonstrated Ca2+ accumulation in ischemic-condensed neurons in heavily injured parts of the brain (9) . Some "C a2+-entry blockers" have been shown to be active in experimental cerebral ischemia models. We were presently interested to see whether "Ca2+-entry blockers" were also protective in simple screening models, where the involvement of Ca2+ in toxicity is less obvious.
A discussion of the different tests which have been used here is necessary in order to facilitate the interpretation of the results. First, exposing rats to an environment of 100% nitrogen produces anoxia.
In an unpublished study we found arterial PO2 to be near zero at the end of the one-minute nitrogen exposure. It was previously found that protection by drugs was uniformly related to a maintenance of normocapnia (18) . Drugs providing such protective action might do so in different ways. Untreated rats appear to respond to the hypoxic stimulus by a classic 'fight or flight' reaction.
Massive increases in sympathetic outflow lead to an increase in peripheral vascular resistance, cardiac output and pulmonary blood flow. Effective drugs (see Table 4 ) may act by minimizing peripheral vasoconstriction. A maintenance of normocapnia may then be sufficient to stimulate the respiratory center (18) .
Second, in the complete ischemia test in mice, the prolongation of gasping responses is the measure of an anti-ischemic effect. Obviously, the ischemia itself cannot be prevented, but drugs might preserve the integrity of nerve cells of the respiratory center. Sustained neuronal function in the respiratory center would then lead to pro longed gasping. Maintenance of membrane stability might be involved in this form of ischemia.
Third, the lethality caused by an injection of KCN is largely due to the inhibition of cytochrome oxidase and the subsequent breakdown of cellular metabolism leading to a disruption of cellular integrity (19). The protection against KCN might not be due to an inhibition of mitochondrial energy pro duction but rather to a protection against cellular constituents formed when the energy production is disrupted.
The potent an tagonistic effects of beta-adrenergic agonists against KCN seem to be due to an increased tissue perfusion which suggests that the acute lethality is due to an abrupt circulatory shock (20). Thus both cellular protective mechanisms and increased tissue perfusion without compromising the heart may be involved in the protection against KCN lethality. A similar mechanism may hold for the effects seen with flunarizine.
Finally, inactivity in the bicuculline seizure test means either no anticonvulsant activity or no brain penetration. Bicuculline has been used as the substance to provoke seizures because of its specific inhibitory effect on GABA neurotransmission.
GABA is also involved in hypoxia (211 ), but the disturbance is rather related to a disruption of the turnover of neuronal GABA rather than to steady state tissue concentration (22). Table 4 presents a summary of the actions of the group of "Ca2+-entry blockers" in the 4 tests. The compounds blocking Ca2+-entry into smooth and striated muscle (verapamil, D-600, tiapamil and diltiazem) show little or no activity. The dihydropyridines showed a dose-related protection against "hypoxia" and "Ischemia", but not all compounds were active with respect to "metabolic intoxication" and "seizure" antagonism.
Flunarizine was active in all the tests. Thus, both dihydro pyridines and flunarizine were active, although their primary site of Ca-antagonism in the peripheral system is different.
These tests cannot delineate whether drug activity was due to vascular and/or neuronal mechanisms or whether activity was due to "Ca2+ -entry blockade" . However, some data is available which can clarify these questions to some extent. Firstly, if verapamil, tiapamil, D-600 and diltiazem were inactive because of poor brain penetrability, then vascular mechanisms of the type found in peripheral smooth muscle are insufficient to provide protection. Secondly, the active doses of the dihydropyridine compounds are higher than those required to produce negative iono trophic effects on the heart in vivo. Thus, either poor brain penetrability requires higher doses for anti-hypoxic effects or their action is unrelated to blockade of the voltage dependent Cat'-channels of the type found in heart muscle. A third Possibility is that the cerebral vasculature shows a different mecha nism of reactivity to stimuli than the peripheral vasculature (23) 
